Table of contents
August 2003 Vol 3 No 8
In this issue
p547 | doi:10.1038/nrc1163
Research Highlights
Metastasis: From breast to bone...
p549 | doi:10.1038/nrc1155
Metastasis: Keep moving
p550 | doi:10.1038/nrc1157
Web Watch
Research resource
p550 | doi:10.1038/nrc1161
Therapeutic targets: TORpedoing cancer cells
p551 | doi:10.1038/nrc1152
In brief
Angiogenesis | Immunotherapy | Mouse Models | Tumour suppressors
p551 | doi:10.1038/nrc1156
Risk and prevention: An aspirin a day...
p552 | doi:10.1038/nrc1149
Therapeutics: How degrading!
p552 | doi:10.1038/nrc1150
Genetics: Locating low-penetrance genes
p553 | doi:10.1038/nrc1153
Trial Watch
Cautious enthusiasm
p553 | doi:10.1038/nrc1160
Metastasis: Chain-store cancer
p554 | doi:10.1038/nrc1148
Telomerase: Pathways to telomerase activation
p554 | doi:10.1038/nrc1154
Oncogenes: Who's doing the dirty work for MYC?
p555 | doi:10.1038/nrc1158
News and Analysis
Fresh from the Pipeline
Gefitinib
p556 | doi:10.1038/nrc1159
Reviews
The genetics of malignant melanoma: lessons from mouse and man
Lynda Chin
p559 | doi:10.1038/nrc1145
Caveolae: mining little caves for new cancer targets
Lucy A. Carver & Jan E. Schnitzer
p571 | doi:10.1038/nrc1146
The emerging role of lysophosphatidic acid in cancer
Gordon B. Mills & Wouter H. Moolenaar
p582 | doi:10.1038/nrc1143
Control of gut differentiation and intestinal-type gastric carcinogenesis
Yasuhito Yuasa
p592 | doi:10.1038/nrc1141
Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms
Sergio A. Lamprecht & Martin Lipkin
p601 | doi:10.1038/nrc1144
Clinical development of gene therapy for colorectal cancer
David Kerr
p615 | doi:10.1038/nrc1147
Perspective
Opinion
Telomere dysfunction and the initiation of genome instability
David M. Feldser, Jennifer A. Hackett & Carol W. Greider
p623 | doi:10.1038/nrc1142